Home/Filings/4/0001537250-13-000003
4//SEC Filing

Tribute Pharmaceuticals Canada Inc. 4

Accession 0001537250-13-000003

CIK 0001159019operating

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 2:46 PM ET

Size

5.6 KB

Accession

0001537250-13-000003

Insider Transaction Report

Form 4
Period: 2013-06-24
Harris Robert Paul
DirectorChief Executive Officer
Transactions
  • Award

    Share Options

    2013-06-24$0.40/sh+90,000$36,0001,124,276 total
    Exercise: $0.40From: 2013-09-30Exp: 2018-06-20Common Shares (90,000 underlying)
Footnotes (2)
  • [F1]Actual exercise price will be in Cdn dollars ($0.42)
  • [F2]Optioms will vest 7,500 the last day of each quarter over the next three years

Issuer

Tribute Pharmaceuticals Canada Inc.

CIK 0001159019

Entity typeoperating
IncorporatedOntario, Canada

Related Parties

1
  • filerCIK 0001159019

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 2:46 PM ET
Size
5.6 KB